Resources

Your selections:

Clear all

Show Filters

We found 254 resources that match your search.

Financial Disclosure Form for Non-networks

Non-network financial disclosure/certification form.

Document Date:

Financial Disclosure Forms for ACTG

AIDS clinical trials group network IND study financial disclosure form. .zip file includes ACTG Network IND Study Financial Disclosure Form (PDF) ACTG Network IND Study Financial Disclosure Form Template (PDF) ACTG Network IND Study Financial Disclosure Form Fillable (PDF)  

Document Date:

Fluconazole (Diflucan) Package Insert

DIFLUCAN (fluconazole), the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration, as a powder for oral suspension.

GEO-D02 and MVA-HIV62B Vaccine

Document Date:

GEO-D03 and MVA-HIV62B Vaccines (Preventative)

Document Date:

GLA-SE

Document Date:

Glecaprevir and Pibrentasvir

Document Date:

GSK1265744 (Cabotegravir)

Document Date:

Guidelines for Electronic Submissions Via Email-EPR Guidelines

Guidelines for Electronic Submissions Via Email-EPR Guidelines

Document Date:

HEC Placebo Gel

Hepatitis B Vaccine Recombinant (Engerix-B)

Document Date:

Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B)

Document Date:

Hepatitis B Vaccine Recombinant, Adjuvanted (Heplisav-B) Investigator's Brochure

Document Date:

High Level Summary of Changes for the Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0

The Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 2.0 contains a number of changes detailed below when compared with the Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0 – December 2004 (…

Document Date:

HIV-1 Multiantigen pDNA Vaccine and Human IL-12 pDNA

Document Date:

HPTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains Presentation to HPTN/IMPAACT Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course Expedited reporting via DAERS - Case Study

Document Date:

HVTN - Expedited Reporting to DAIDS and DAERS Refresher

.zip file contains: Presentation to HVTN Annual Meeting on Expedited Reporting to DAIDS and DAERS refresher course; Expedited reporting via DAERS - Case Study

Document Date:

Hydroxychloroquine Sulfate Package Insert

Document Date:

IBC RAC Guidance

Guidance and requirements for daids-supported research involving recombinant DNA.

Document Date:

IHV01

Document Date:

Imatinib Mesylate Package Insert

Document Date:

IMPAACT - Expedited Reporting to DAIDS and DAERS Refresher

.zip files contains: Safety training presentation on expedited reporting to DAIDS and a refresher on DAERS Case study handout Meeting for HPTN and IMPAACT networks was held June 2016.

Document Date:

IND Protocol Lists

List of IND protocols having CRF/Pharmacy records that will not be stored by DAIDS.

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Document Date:

Instructions for Authorization and Transfer of CRFs and Pharmacy Records to the DAIDS RSC

Instructions for the transfer of case report forms, (CRF) and pharmacy records to the DAIDS regulatory support center, (DAIDS RSC).

Document Date: